The current status of orphan drugs management in taiwan

• In: Posters: Social and Administrative Pharmacy Section
• At: Bangkok (Thailand) (2014)
• Type: Poster
• Poster code: POSSAPS007
• By: HSIEH, Yow-Wen (China Medical University Hospital, Pharmacy, Taichung, China Taiwan)
• Co-author(s): Cheng, Yih-Dih (China Medical University Hospital, Taichung, China Taiwan)
  Deng, Shin-Tarng (Linkou Chang Gung Memorial Hospital, Taoyuan, China Taiwan)
  Jiang, Ruey-Ling (Da Chien General Hospital, Miaoli city, China Taiwan)
  Lai, Ya-Yun (National Tainan Junior College of Nursing, Tainan, China Taiwan)
  Chi, Jo-Feng (Food and Drug Administration, Ministry of Health and Welfare, Taipei, China Taiwan)
  Huang, Shu-Ping (Food and Drug Administration, Ministry of Health and Welfare, Taipei, China Taiwan)
  
• Abstract:

  Abstract
  Background:
  In recent years, rare disease is an important public health issue and a challenge to medical care. In addition to devoted to develop the treatments of rare diseases, we also have formulated management regulation. Until March, 2014, a total of 201 orphan diseases and 85 orphan drugs have been defined, and 40 different formulas..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login